Enhabit (EHAB) Competitors

Addus HomeCare (NASDAQ:ADUS) and Enhabit (NYSE:EHAB) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.

Does the media refer more to ADUS or EHAB?

In the previous week, Addus HomeCare had 4 more articles in the media than Enhabit. MarketBeat recorded 7 mentions for Addus HomeCare and 3 mentions for Enhabit. Enhabit's average media sentiment score of 1.48 beat Addus HomeCare's score of 1.45 indicating that Enhabit is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Enhabit	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher earnings and valuation, ADUS or EHAB?

Addus HomeCare has higher revenue and earnings than Enhabit. Enhabit is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.15B	1.53	$62.52M	$4.24	22.95
Enhabit	$1.03B	0.42	-$80.50M	-$3.11	-2.78

Do analysts prefer ADUS or EHAB?

Addus HomeCare presently has a consensus price target of $132.78, suggesting a potential upside of 36.46%. Enhabit has a consensus price target of $8.50, suggesting a potential downside of 1.67%. Given Addus HomeCare's stronger consensus rating and higher probable upside, research analysts clearly believe Addus HomeCare is more favorable than Enhabit.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	3.00
Enhabit	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has more risk & volatility, ADUS or EHAB?

Addus HomeCare has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.8, suggesting that its share price is 80% more volatile than the S&P 500.

Does the MarketBeat Community believe in ADUS or EHAB?

Addus HomeCare received 324 more outperform votes than Enhabit when rated by MarketBeat users. Likewise, 68.83% of users gave Addus HomeCare an outperform vote while only 17.24% of users gave Enhabit an outperform vote.

Company	Underperform	Outperform
Addus HomeCare	Outperform Votes 329 68.83%	Underperform Votes 149 31.17%
Enhabit	Outperform Votes 5 17.24%	Underperform Votes 24 82.76%

Is ADUS or EHAB more profitable?

Addus HomeCare has a net margin of 6.50% compared to Enhabit's net margin of -11.24%. Addus HomeCare's return on equity of 9.62% beat Enhabit's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	6.50%	9.62%	7.37%
Enhabit	-11.24%	1.67%	0.80%

Do insiders & institutionals hold more shares of ADUS or EHAB?

95.3% of Addus HomeCare shares are owned by institutional investors. 4.6% of Addus HomeCare shares are owned by insiders. Comparatively, 1.9% of Enhabit shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Addus HomeCare beats Enhabit on 17 of the 19 factors compared between the two stocks.